Clinical Trial Update: Dapagliflozin in STEMI [Phase 3]

View source ↗

Summary

A Phase 3 trial evaluating dapagliflozin in ST-elevation myocardial infarction is currently recruiting. The study is sponsored by the Ottawa Heart Institute Res…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Myocardial Infarction
• St-elevation Myocardial Infarction

Drugs mentioned

• FARXIGA (dapagliflozin)

Snippet

Sponsor: Ottawa Heart Institute Research Corporation | Conditions: ST Elevation Myocardial Infarction, Myocardial Infarction | Phase 3 | Status: RECRUITING